GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CombiGene AB (OSTO:COMBI) » Definitions » Long-Term Debt

CombiGene AB (OSTO:COMBI) Long-Term Debt : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is CombiGene AB Long-Term Debt?

CombiGene AB's Long-Term Debt for the quarter that ended in Dec. 2024 was kr0.00 Mil.

CombiGene AB Long-Term Debt Historical Data

The historical data trend for CombiGene AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CombiGene AB Long-Term Debt Chart

CombiGene AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only - - - - -

CombiGene AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CombiGene AB  (OSTO:COMBI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

CombiGene AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of CombiGene AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CombiGene AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CombiGene AB (OSTO:COMBI) » Definitions » Long-Term Debt
Comparable Companies
XSAT:NIDHOG OSTO:EXPRS2 OSTO:SPRINT OSTO:ONCOZ OSTO:MODTX XSAT:CHOSA OSTO:ACOU OSTO:SIMRIS B OSTO:CMOTEC B XSAT:RESP VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Agavagen 52A, Lidingo, SWE, SE-181 55
Website
https://www.combigene.com
CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present. It develops gene therapies with the ambition to offer patients affected by severe life-changing diseases opportunities for a better life.

CombiGene AB Headlines

No Headlines